rs121913561
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 5P and 1B. PP3_StrongPP5BS2_Supporting
The NM_005912.3(MC4R):c.821A>G(p.Asn274Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000867 in 1,614,046 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_005912.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MC4R | NM_005912.3 | c.821A>G | p.Asn274Ser | missense_variant | 1/1 | ENST00000299766.5 | NP_005903.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MC4R | ENST00000299766.5 | c.821A>G | p.Asn274Ser | missense_variant | 1/1 | 6 | NM_005912.3 | ENSP00000299766.3 | ||
ENSG00000285681 | ENST00000650201.1 | n.113+42184T>C | intron_variant | |||||||
ENSG00000285681 | ENST00000658928.1 | n.156+42184T>C | intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251348Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135838
GnomAD4 exome AF: 0.00000889 AC: 13AN: 1461876Hom.: 0 Cov.: 31 AF XY: 0.00000688 AC XY: 5AN XY: 727242
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152170Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74338
ClinVar
Submissions by phenotype
BODY MASS INDEX QUANTITATIVE TRAIT LOCUS 20 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Jul 01, 2001 | - - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2022 | - - |
Obesity Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Aug 22, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. - |
MC4R-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 08, 2023 | The MC4R c.821A>G variant is predicted to result in the amino acid substitution p.Asn274Ser. This variant has been reported in multiple individuals with severe obesity (Mergen et al. 2001. PubMed ID: 11443223; Stutzmann et al. 2008. PubMed ID: 18559663; Reinehr et al. 2009. PubMed ID: 18997677; Yurtcu et al. 2009. PubMed ID: 19184404; Rouskas et al. 2012. PubMed ID: 22447289; Mühlhaus et al. 2012. PubMed ID: 22688572; Aykut et al. 2020. PubMed ID: 32185475); however, it has also been detected at least twice in control cohorts of non-obese individuals (Yurtcu et al. 2009. PubMed ID: 19184404; Rouskas et al. 2012. PubMed ID: 22447289). Moreover, in vitro studies have demonstrated that MC4R protein carrying the p.Asn274Ser variant has normal cell surface expression and ligand binding affinity comparable to wild type protein (Tao et al. 2003. PubMed ID: 12959994; Xiang et al. 2006. PubMed ID: 16752916). Additional experiments also found similar levels of cyclic AMP production and MAPK signaling pathway activation following stimulation by endogenous and synthetic receptor agonists (Tao et al. 2003. PubMed ID: 12959994; Xiang et al. 2006. PubMed ID: 16752916; He et al. 2014. PubMed ID: 25332687). This variant is reported in 0.0018% of alleles in individuals of European (Non-Finnish) descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at